Clinical Trials
5
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Hypoxic Red Blood Cells in Sickle Cell Anemia
- Conditions
- Sickle Cell AnaemiaSickle Cell Anemia CrisisSickle Cell Anemia in ChildrenSickle Cell Anemia (HbSS, or HbSβ-thalassemia0)
- First Posted Date
- 2024-12-19
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Hemanext
- Target Recruit Count
- 48
- Registration Number
- NCT06743113
- Locations
- 🇺🇸
New England Sickle Cell Institute, University of Connecticut, Farmington, Connecticut, United States
🇺🇸Johns Hopkins All Children's Hospital, Saint Petersburg, Florida, United States
🇺🇸Emory University School of Medicine, Atlanta, Georgia, United States
Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion
- Conditions
- Hematologic Neoplasms
- First Posted Date
- 2024-11-13
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Hemanext
- Target Recruit Count
- 24
- Registration Number
- NCT06685848
- Locations
- 🇳🇴
Haukeland University Hospital, Bergen, Norway
Hypoxic Red Blood Cells for Burns and Hematological Malignancies at Haukeland University Hospital
- Conditions
- Hematologic NeoplasmsBurns
- First Posted Date
- 2022-09-22
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Hemanext
- Target Recruit Count
- 22
- Registration Number
- NCT05549232
- Locations
- 🇳🇴
Haukeland University Hospital, Bergen, Norway
Clinical Investigation to Evaluate the Hemanext® Red Blood Cell Processing System for Extended Storage of Leukoreduced Red Blood Cells
- Conditions
- Whole Blood Donations and Leukoreduction
- First Posted Date
- 2020-06-05
- Last Posted Date
- 2020-08-03
- Lead Sponsor
- Hemanext
- Registration Number
- NCT04418934
- Locations
- 🇺🇸
Hoxworth Blood Center, University of Cincinnati, Cincinnati, Ohio, United States
🇺🇸American Red Cross Mid-Atlantic Research Facility, Norfolk, Virginia, United States
Clinical Investigation to Evaluate the Hemanext® Oxygen Reduction System - Pivotal Trial
- Conditions
- Whole Blood Donation and Leukoreduction
- First Posted Date
- 2017-10-04
- Last Posted Date
- 2020-06-23
- Lead Sponsor
- Hemanext
- Target Recruit Count
- 100
- Registration Number
- NCT03301779
- Locations
- 🇺🇸
Hoxworth Blood Center, University of Cincinnati, Cincinnati, Ohio, United States
🇺🇸American Red Cross Mid-Atlantic Research Facility, Norfolk, Virginia, United States
🇺🇸Blood Center of Wisconsin, Milwaukee, Wisconsin, United States